As of May 2024 Sarepta Therapeutics has a market cap of $12.53 Billion. This makes Sarepta Therapeutics the world's 1381th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $12.53 B | 39.01% |
2023 | $9.02 B | -20.7% |
2022 | $11.37 B | 45.06% |
2021 | $7.84 B | -41.72% |
2020 | $13.45 B | 38.67% |
2019 | $9.70 B | 25.09% |
2018 | $7.75 B | 115.68% |
2017 | $3.59 B | 140.16% |
2016 | $1.49 B | -14.94% |
2015 | $1.76 B | 194.49% |
2014 | $0.59 B | -22.27% |
2013 | $0.76 B | -5.98% |
2012 | $0.81 B | 708.83% |
2011 | $0.10 B | -57.54% |
2010 | $0.23 B | 47.65% |
2009 | $0.16 B | 244.53% |
2008 | $46.82 M | -48.47% |
2007 | $90.87 M | -46.27% |
2006 | $0.16 B | -4.22% |
2005 | $0.17 B | 107.9% |
2004 | $84.93 M | -39.45% |
2003 | $0.14 B | 5.62% |
2002 | $0.13 B | -47.63% |
2001 | $0.25 B |
On May 14th, 2024 the market cap of Sarepta Therapeutics was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Gilead Sciences GILD | $84.28 B | 572.13% | ๐บ๐ธ USA |
PTC Therapeutics
PTCT | $2.39 B | -80.93% | ๐บ๐ธ USA |
Novavax NVAX | $1.89 B | -84.91% | ๐บ๐ธ USA |
Alnylam Pharmaceuticals
ALNY | $18.70 B | 49.18% | ๐บ๐ธ USA |
Insmed INSM | $3.78 B | -69.84% | ๐บ๐ธ USA |
BioCryst Pharmaceuticals
BCRX | $1.10 B | -91.18% | ๐บ๐ธ USA |
Avidity Biosciences RNA | $2.76 B | -77.95% | ๐บ๐ธ USA |